266 related articles for article (PubMed ID: 11592936)
1. Targeted disruption of the bradykinin B(2) receptor gene in mice alters the ontogeny of the renin-angiotensin system.
Yosipiv IV; Dipp S; El-Dahr SS
Am J Physiol Renal Physiol; 2001 Nov; 281(5):F795-801. PubMed ID: 11592936
[TBL] [Abstract][Full Text] [Related]
2. Potent antihypertrophic effect of the bradykinin B2 receptor system on the renal vasculature.
Tsuchida S; Miyazaki Y; Matsusaka T; Hunley TE; Inagami T; Fogo A; Ichikawa I
Kidney Int; 1999 Aug; 56(2):509-16. PubMed ID: 10432390
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular phenotypes of kinin B2 receptor- and tissue kallikrein-deficient mice.
Trabold F; Pons S; Hagege AA; Bloch-Faure M; Alhenc-Gelas F; Giudicelli JF; Richer-Giudicelli C; Meneton P
Hypertension; 2002 Jul; 40(1):90-5. PubMed ID: 12105144
[TBL] [Abstract][Full Text] [Related]
4. Renal and blood pressure phenotype in 18-mo-old bradykinin B2R(-/-)CRD mice.
Harrison-Bernard LM; Dipp S; El-Dahr SS
Am J Physiol Regul Integr Comp Physiol; 2003 Oct; 285(4):R782-90. PubMed ID: 12805091
[TBL] [Abstract][Full Text] [Related]
5. Interactions of the kallikrein-kinin and renin-angiotensin systems in experimental diabetes.
Vora JP; Oyama TT; Thompson MM; Anderson S
Diabetes; 1997 Jan; 46(1):107-12. PubMed ID: 8971089
[TBL] [Abstract][Full Text] [Related]
6. Type 2 bradykinin-receptor antagonism does not modify kinin or angiotensin peptide levels.
Campbell DJ; Kladis A; Briscoe TA; Zhuo J
Hypertension; 1999 May; 33(5):1233-6. PubMed ID: 10334817
[TBL] [Abstract][Full Text] [Related]
7. Enhanced renal function in bradykinin B(2) receptor transgenic mice.
Wang D; Yoshida H; Song Q; Chao L; Chao J
Am J Physiol Renal Physiol; 2000 Mar; 278(3):F484-91. PubMed ID: 10710553
[TBL] [Abstract][Full Text] [Related]
8. Myelopoiesis modulation by ACE hyperfunction in kinin B(1) receptor knockout mice: relationship with AcSDKP levels.
Oliveira CR; Paredes-Gamero EJ; Barbosa CM; Nascimento FD; Batista EC; Reis FC; Martins AH; Ferreira AT; Carmona AK; Pesquero JB; Tersariol IL; Araújo RC; Bincoletto C
Chem Biol Interact; 2010 Mar; 184(3):388-95. PubMed ID: 20096676
[TBL] [Abstract][Full Text] [Related]
9. The intrarenal renin-angiotensin system in autosomal dominant polycystic kidney disease.
Loghman-Adham M; Soto CE; Inagami T; Cassis L
Am J Physiol Renal Physiol; 2004 Oct; 287(4):F775-88. PubMed ID: 15187005
[TBL] [Abstract][Full Text] [Related]
10. Effects of mineralocorticoid receptor gene disruption on the components of the renin-angiotensin system in 8-day-old mice.
Hubert C; Gasc JM; Berger S; Schütz G; Corvol P
Mol Endocrinol; 1999 Feb; 13(2):297-306. PubMed ID: 9973259
[TBL] [Abstract][Full Text] [Related]
11. Salt intake modulates the developmental expression of renal kallikrein and bradykinin B2 receptors.
el-Dahr S; Yosipiv IV; Muchant DG; Chevalier RL
Am J Physiol; 1996 Mar; 270(3 Pt 2):F425-31. PubMed ID: 8780244
[TBL] [Abstract][Full Text] [Related]
12. Developmental regulation of ACE gene expression by endogenous kinins and angiotensin II.
Yosipiv IV; el-Dahr SS
Am J Physiol; 1995 Aug; 269(2 Pt 2):F172-9. PubMed ID: 7544538
[TBL] [Abstract][Full Text] [Related]
13. The renin-angiotensin and the kallikrein-kinin systems.
Campbell DJ
Int J Biochem Cell Biol; 2003 Jun; 35(6):784-91. PubMed ID: 12676165
[TBL] [Abstract][Full Text] [Related]
14. Ontogeny of the intrarenal kallikrein-kinin system: proposed role in renal development.
el-Dahr SS
Microsc Res Tech; 1997 Nov; 39(3):222-32. PubMed ID: 9372496
[TBL] [Abstract][Full Text] [Related]
15. Bradykinin B2 null mice are prone to renal dysplasia: gene-environment interactions in kidney development.
El-Dahr SS; Harrison-Bernard LM; Dipp S; Yosipiv IV; Meleg-Smith S
Physiol Genomics; 2000 Sep; 3(3):121-31. PubMed ID: 11015607
[TBL] [Abstract][Full Text] [Related]
16. Role of endothelin receptors in the hypertensive state of kinin B(2) knockout mice subjected to a high-salt diet.
Brochu I; Labonté J; Bkaily G; D'Orléans-Juste P
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():380S-384S. PubMed ID: 12193127
[TBL] [Abstract][Full Text] [Related]
17. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin.
Nagai N; Oike Y; Izumi-Nagai K; Koto T; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Ishida S
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2321-6. PubMed ID: 17460297
[TBL] [Abstract][Full Text] [Related]
18. Effect of genetic deficiency of angiotensinogen on the renin-angiotensin system.
Tamura K; Umemura S; Sumida Y; Nyui N; Kobayashi S; Ishigami T; Kihara M; Sugaya T; Fukamizu A; Miyazaki H; Murakami K; Ishii M
Hypertension; 1998 Aug; 32(2):223-7. PubMed ID: 9719046
[TBL] [Abstract][Full Text] [Related]
19. Multiple interactions between the renin-angiotensin and the kallikrein-kinin systems: role of ACE inhibition and AT1 receptor blockade.
Tschöpe C; Schultheiss HP; Walther T
J Cardiovasc Pharmacol; 2002 Apr; 39(4):478-87. PubMed ID: 11904521
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin AT(1) receptor signalling modulates reparative angiogenesis induced by limb ischaemia.
Emanueli C; Salis MB; Stacca T; Pinna A; Gaspa L; Madeddu P
Br J Pharmacol; 2002 Jan; 135(1):87-92. PubMed ID: 11786483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
